1.33 -0.08 (-5.59%)
ARYX
Stock Details
Last Trade:1.33 Change:-0.08 (-5.59%) Prev Close:1.41 Open: 1.43 Days Range:1.31 – 1.45 52 Week Range: 1.37 - 6.32 Volume:1308155 P/E: N/AEPS:-1.62
View AllRecent Alerts 02/24/10
Recent Alert on 02/22/10 at 7:54am
Oppenheimer Downgrades ARYx Therapeutics (ARYX) to Perform
Oppenheimer Downgrades ARYx Therapeutics (ARYX) to Perform
Oppenheimer downgrades ARYx Therapeutics (Nasdaq: ARYX) from Outperform to Perform. To see all the upgrades/downgrades on shares of ARYX, visit our Analyst Ratings page. ARYx Therapeutics, Inc. (ARYx) is a biopharmaceutical company focused on... Read More
Recent Alert on 02/19/10 at 12:30pm
Unusual 11 Mid-Day Movers 2/19: PIII, RAS, MHJ, NR, DRAM Higher; ARYX, ES, MMSI, ELGX Lower
Unusual 11 Mid-Day Movers 2/19: PIII, RAS, MHJ, NR, DRAM Higher; ARYX, ES, MMSI, ELGX Lower
Recent Alert on 02/19/10 at 9:55am
Morning Movers 2/19: COBR, SII, COBK, RAS Higher; ARYX, ES, MMSI, CSIQ, SLXP, ACPW Lower
Morning Movers 2/19: COBR, SII, COBK, RAS Higher; ARYX, ES, MMSI, CSIQ, SLXP, ACPW Lower
Recent Alert on 01/05/10 at 8:14am
ARYx Therapeutics (ARYX) Receives U.S. FDA Guidance Regarding Anticoagulant Agent Tecarfarin
ARYx Therapeutics (ARYX) Receives U.S. FDA Guidance Regarding Anticoagulant Agent Tecarfarin
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 11/01/09 at 4:03am
Biotech Tribulations Roundup: Failed Trials, Missed Targets, Business Mishaps
Biotech Tribulations Roundup: Failed Trials, Missed Targets, Business Mishaps